Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00901095 · ClinicalTrials.gov registry record · Phase 2
Can Diet- and Exercise-Induced Weight Loss Improve Asthma Control in Adults?
A Phase 2 study, sponsored by Palo Alto Medical Foundation.
- Completed
- Registry status
- Phase 2
- Development phase
- 330
- Enrollment target
NCT00901095: Completed Phase 2 study, sponsored by Palo Alto Medical Foundation.
NCT00901095 is a Phase 2 study that has completed, run by Palo Alto Medical Foundation. The registered enrollment target is 330 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (148% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00901095, a Phase 2 study, has completed, sponsored by Palo Alto Medical Foundation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 330 participants
- Enrollment target
Study Summary
The goal of the study is to investigate the efficacy of an evidence-based weight loss intervention, on a background of quality health care, on asthma control among obese adults. The intervention will employ a combination of recommended dietary and physical activity changes, and behavioral modification techniques.
Interventions
- BEHAVIORAL Lifestyle intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2010-02 |
| Est. Completion | 2014-03 |
| Phase | Phase 2 |
What the finished NCT00901095 record still lists
NCT00901095 is an interventional study that assigns participants to a tested intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (148% higher).
The record links to 0 conditions, and to 1 intervention - of which Lifestyle intervention is the first listed.
NCT00901095 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00901095 about?
NCT00901095 is a clinical study titled "Can Diet- and Exercise-Induced Weight Loss Improve Asthma Control in Adults?". The goal of the study is to investigate the efficacy of an evidence-based weight loss intervention, on a background of quality health care, on asthma control among obese adults. The intervention will employ a combination of recommended dietary and physical activity changes, and behavioral modificati...
What is the current status of trial NCT00901095?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 330 participants. The study started on 2010-02. Estimated completion is 2014-03.
What interventions are being tested in trial NCT00901095?
The interventions under investigation include: Lifestyle intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00901095?
This trial is sponsored by Palo Alto Medical Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00901095's enrollment target sits among peer trials
330 145th of 2000 higher than 1,855 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT03932773 · 330 participants · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia